BAGUERA® C 10-year clinical follow-up study in the European Spine Journal

After the 5-Year clinical results published in 2018, we are proud to announce that the European Spine Journal has just published the 10-Year results.

81 patients continued their follow up to 10-years and the results confirm the long-term performance and safety of the device. In a nutshell, at 10 years the range of motion is preserved in 86.6% of the patients, the upper adjacentdisc height is preserved with no degeneration, compared with the pre-operative height. There are no long-term device or surgery related complications and no progressive osteolysis is observed.

We look forward to seeing the 15-Year results!

Discover the full article

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporativo
  For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...
  • Innovación
Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...
  • BAGUERA® C
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...